Added Clinical Value of Intraplaque Neovascularization Detection to Color Doppler Ultrasound for Assessing Ischemic Stroke Risk
DOI: https://doi.org/10.2147/ndt.s456872
IF: 2.989
2024-04-24
Neuropsychiatric Disease and Treatment
Abstract:Liuping Cui, 1, 2 Ran Liu, 1 Fubo Zhou, 1 Yumei Liu, 1 Bing Tian, 1 Ying Chen, 2, &ast Yingqi Xing 1, 3, 4, &ast 1 Department of Vascular Ultrasound, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Department of Neurology, The First Hospital of Jilin University, Changchun, People's Republic of China; 3 Beijing Diagnostic Center of Vascular Ultrasound, Beijing, People's Republic of China; 4 Center of Vascular Ultrasound, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingqi Xing, Department of Vascular Ultrasonography, Xuanwu Hospital, Capital Medical University, 45 Changchun Road, Beijing, Xicheng District, 100053, People's Republic of China, Tel +86-18610047846, Email Purpose: Intraplaque neovascularization, assessed using contrast-enhanced ultrasound (CEUS), is associated with ischemic stroke. It remains unclear whether detection of intraplaque neovascularization combined with color Doppler ultrasound (CDUS) provides additional value compared with CDUS alone in assessing ischemic stroke risk. Therefore, we investigated the clinical value of combined CEUS, CDUS, and clinical features for ischemic stroke risk stratification. Patients and Methods: We recruited 360 patients with ≥ 50% carotid stenosis between January 2019 and September 2022. Patients were examined using CDUS and CEUS. Covariates associated with ischemic stroke were identified using multivariate logistic regression analysis. The discrimination and calibration were verified using the C-statistic and Hosmer–Lemeshow test. The incremental value of intraplaque neovascularization in the assessment of ischemic stroke was analyzed using the Delong test. Results: We analyzed the data of 162 symptomatic and 159 asymptomatic patients who satisfied the inclusion and exclusion criteria, respectively. Based on multivariate logistic regression analysis, we constructed a nomogram using intraplaque neovascularization, degree of carotid stenosis, plaque hypoechoicity, and smoking status, with a C-statistic of 0.719 (95% confidence interval [CI]: 0.666– 0.768) and a Hosmer–Lemeshow test p value of 0.261. The net reclassification index of the nomogram was 0.249 (95% CI: 0.138– 0.359), and the integrated discrimination improvement was 0.053 (95% CI: 0.029– 0.079). Adding intraplaque neovascularization to the combination of CDUS and clinical features (0.672; 95% CI: 0.617– 0.723) increased the C-statistics ( p =0.028). Conclusion: Further assessment of intraplaque neovascularization after CDUS may help more accurately identify patients at risk of ischemic stroke. Combining multiparametric carotid ultrasound and clinical features may help improve the risk stratification of patients with ischemic stroke with ≥ 50% carotid stenosis. Plain Language Summary: We studied whether using contrast-enhanced ultrasound (CEUS) to detect intraplaque neovascularization could help better determine the risk of ischemic stroke. We compared the combined use of color Doppler ultrasound (CDUS) and CEUS with CDUS alone in patients with more than 50% carotid narrowing. Our findings showed that combining clinical details, CDUS, and CEUS was more effective (0.719 vs 0.672). This means that CEUS provides extra insight when gauging ischemic stroke risk compared with CDUS alone. This could help in accurately identifying patients at high risk of stroke. However, more extensive studies are needed to fully understand the role of these tests in the evaluation of stroke risk. Keywords: atherosclerosis, contrast-enhanced ultrasound, vulnerable plaque, carotid ultrasound Graphical Ischemic stroke contributes greatly to the declining quality of life in middle-aged and older adults. The TOAST classification highlights five etiologies of ischemic stroke, and large-artery atherosclerotic cerebral infarction and cardioembolic infarction are the acute ischemic stroke subtypes with the highest occurrence of early in-hospital mortality. Moreover, the short-term prognosis of patients with atherothrombotic or cardioembolic stroke is poor compared with that of patients with other acute ischemic stroke subtypes. 1,2 The risk of subsequent adverse events remains high even in patients with minor ischemic stroke, especially in patients with large atherosclerotic arteries. 3 Approximately 25% of ischemic stroke cases are caused by atherosclerosis, and current guide -Abstract Truncated-
psychiatry,clinical neurology